Amicus Therapeutics (FOLD)
(Delayed Data from NSDQ)
$10.40 USD
-0.03 (-0.29%)
Updated May 3, 2024 04:00 PM ET
After-Market: $10.38 -0.02 (-0.19%) 7:58 PM ET
4-Sell of 5 4
F Value C Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/09/2024
Time: BMO |
3/2024 | $-0.06 | -62.16% |
Earnings Summary
For their last quarter, Amicus Therapeutics (FOLD) reported earnings of -$0.11 per share, missing the Zacks Consensus Estimate of -$0.06 per share. This reflects a negative earnings surprise of 83.33%. Look out for FOLD's next earnings release on May 09, 2024. For the next earning release, we expect the company to report earnings of -$0.06 per share, reflecting a year-over-year increase of 66.67%.
Earnings History
Price & Consensus
Zacks News for FOLD
Will Amicus Therapeutics (FOLD) Report Negative Q1 Earnings? What You Should Know
FOLD: What are Zacks experts saying now?
Zacks Private Portfolio Services